| 0.7 |
4.4 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.7 |
0.7 |
GO:0098534 |
centriole assembly(GO:0098534) |
| 0.7 |
2.0 |
GO:0033214 |
iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.5 |
0.5 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 |
2.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 |
2.1 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.5 |
1.6 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.5 |
1.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 |
1.5 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.5 |
1.5 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.5 |
2.0 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.5 |
1.9 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.5 |
2.4 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.5 |
1.4 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 |
2.9 |
GO:0030421 |
defecation(GO:0030421) |
| 0.5 |
1.4 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.5 |
1.4 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 |
1.8 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.4 |
1.3 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 |
1.3 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.4 |
0.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.4 |
1.6 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 |
1.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.4 |
1.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 |
0.4 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.4 |
2.0 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.4 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 |
1.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 |
1.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.4 |
1.1 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.4 |
1.1 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 |
1.8 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.4 |
0.7 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.4 |
2.5 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.4 |
1.1 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.3 |
1.0 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.3 |
2.1 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.3 |
2.1 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
0.7 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
0.7 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 |
0.3 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.3 |
4.4 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.3 |
1.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.3 |
2.3 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
1.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 |
1.3 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.3 |
0.3 |
GO:0042710 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 |
0.3 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.3 |
1.0 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.3 |
1.6 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.3 |
2.5 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 |
1.5 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.3 |
0.6 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.3 |
1.2 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.3 |
1.8 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.3 |
1.2 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.3 |
7.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 |
1.2 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.3 |
0.3 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.3 |
0.9 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 |
1.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
8.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.3 |
0.9 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.3 |
0.9 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 |
1.7 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 |
1.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.3 |
0.6 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.3 |
1.1 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.3 |
1.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 |
1.1 |
GO:0007402 |
ganglion mother cell fate determination(GO:0007402) |
| 0.3 |
1.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
3.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.3 |
0.8 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 |
1.1 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 |
2.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
0.3 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.3 |
0.8 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.3 |
0.3 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.3 |
1.3 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 |
0.3 |
GO:1904798 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.3 |
1.0 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
0.5 |
GO:0046075 |
dTTP metabolic process(GO:0046075) |
| 0.3 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.2 |
1.0 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 |
0.7 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.2 |
1.0 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.2 |
1.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.2 |
0.2 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.2 |
0.5 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.2 |
1.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.2 |
0.7 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.2 |
1.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.2 |
2.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
0.7 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.2 |
3.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 |
0.7 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.2 |
0.7 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
1.4 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
0.9 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
1.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
1.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 |
0.9 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 |
0.7 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.2 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
0.9 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.2 |
1.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.2 |
0.2 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.2 |
0.6 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 |
0.2 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.2 |
0.6 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 |
0.6 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 |
1.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
1.3 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 |
0.4 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.2 |
0.8 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
0.2 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.2 |
0.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.2 |
0.6 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.2 |
2.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
1.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.6 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 |
0.6 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.2 |
0.6 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.2 |
1.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
0.6 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 |
0.6 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.2 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 |
1.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 |
1.0 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.2 |
1.0 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.2 |
2.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
0.6 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.2 |
0.2 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.2 |
0.8 |
GO:0060907 |
macrophage cytokine production(GO:0010934) positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 |
0.2 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
0.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
0.8 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.2 |
0.6 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.2 |
0.4 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.2 |
0.8 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.2 |
1.0 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 |
1.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
1.2 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
1.0 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.2 |
0.2 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 |
0.6 |
GO:0009436 |
glyoxylate catabolic process(GO:0009436) |
| 0.2 |
0.6 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
2.5 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
1.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.6 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
0.2 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 |
1.9 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
0.6 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
0.6 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 |
0.9 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
0.5 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 |
2.0 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
1.3 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
0.5 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
0.5 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 |
0.2 |
GO:0006956 |
complement activation(GO:0006956) |
| 0.2 |
0.2 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.2 |
0.4 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.2 |
0.5 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.2 |
0.4 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.5 |
GO:1901253 |
negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 |
0.5 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 |
0.2 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.2 |
1.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
1.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
0.7 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
0.3 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.2 |
1.9 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.2 |
0.2 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.2 |
0.7 |
GO:0061358 |
negative regulation of Wnt protein secretion(GO:0061358) |
| 0.2 |
1.0 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.2 |
0.3 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.2 |
0.5 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.2 |
1.0 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
0.2 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.2 |
0.9 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.7 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.2 |
0.2 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.2 |
0.3 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.2 |
1.5 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
0.2 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.2 |
2.2 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
6.4 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 |
0.8 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
9.5 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.2 |
0.7 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
0.5 |
GO:0048936 |
peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.2 |
1.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
1.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
0.7 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
7.1 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.2 |
0.2 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.2 |
0.2 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 |
0.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
0.5 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.2 |
0.5 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.2 |
1.5 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.2 |
0.2 |
GO:1902563 |
regulation of neutrophil activation(GO:1902563) |
| 0.2 |
5.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
0.8 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.2 |
0.8 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.6 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.2 |
0.5 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.2 |
0.2 |
GO:0051651 |
maintenance of location in cell(GO:0051651) |
| 0.2 |
0.2 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.2 |
0.3 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 |
0.6 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
1.6 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 |
0.5 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
1.2 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 |
1.4 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.2 |
0.6 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.5 |
GO:0009216 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.2 |
0.3 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 |
0.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
0.3 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 |
2.0 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
0.2 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
0.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
0.6 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 |
0.6 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 0.1 |
0.1 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.1 |
2.5 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.1 |
0.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.7 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.1 |
0.7 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.1 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.6 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
0.1 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
0.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.1 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.1 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 0.1 |
0.4 |
GO:1903762 |
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.1 |
1.9 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.4 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.6 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 |
0.1 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
0.3 |
GO:0003186 |
tricuspid valve morphogenesis(GO:0003186) |
| 0.1 |
0.3 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.4 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 |
0.4 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
0.3 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.1 |
0.6 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.4 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
3.4 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.1 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 |
0.7 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.1 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.1 |
0.7 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.3 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.1 |
0.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.7 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
1.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.8 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.7 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.3 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.1 |
0.4 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.4 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.1 |
0.4 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.8 |
GO:0034670 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 |
0.4 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.1 |
0.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
1.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.9 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
0.1 |
GO:0048640 |
negative regulation of developmental growth(GO:0048640) |
| 0.1 |
0.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.9 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.1 |
0.4 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
0.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.1 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.1 |
0.8 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.4 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 |
0.5 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.8 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
0.1 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 |
0.8 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.1 |
0.5 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.5 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.1 |
0.9 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
1.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.4 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
2.1 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
1.0 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.5 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 |
0.4 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 |
0.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
3.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
1.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.8 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.1 |
1.3 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.1 |
0.4 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.3 |
GO:0045074 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.1 |
0.9 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.4 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
2.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.5 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.1 |
2.0 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.1 |
GO:0031392 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 |
0.9 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.3 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.1 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
1.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.6 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
0.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.7 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.6 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 |
0.5 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.4 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.4 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
1.2 |
GO:0048296 |
regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.1 |
0.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.5 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
0.2 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.1 |
0.2 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
1.1 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
1.6 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.8 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 |
0.4 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.7 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 |
1.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.2 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.1 |
0.8 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.1 |
2.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.1 |
GO:0098751 |
bone cell development(GO:0098751) |
| 0.1 |
0.5 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.1 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 |
1.8 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 |
1.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 |
0.6 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.2 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.1 |
0.6 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 |
0.1 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.1 |
0.6 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.1 |
1.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
1.0 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.3 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.1 |
0.3 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
2.4 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.2 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
0.3 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.3 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 |
0.7 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
1.9 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 |
1.0 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.3 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.2 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
1.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
3.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.6 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.1 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.1 |
0.1 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
1.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.3 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 |
1.0 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 |
1.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
1.4 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
2.2 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.5 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.5 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 |
0.3 |
GO:0010949 |
negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.1 |
0.4 |
GO:0039506 |
modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.1 |
0.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.1 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 |
0.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
2.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.7 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.3 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 |
0.3 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.1 |
0.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.3 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 |
1.2 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
0.3 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 |
0.6 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.3 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.3 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.1 |
0.4 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
0.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.8 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.2 |
GO:2000729 |
positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.1 |
1.2 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.1 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.3 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.7 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.5 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.1 |
0.1 |
GO:1903051 |
negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
| 0.1 |
0.3 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.3 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 |
0.5 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
0.4 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.2 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.1 |
0.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.7 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.2 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
0.2 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.1 |
0.2 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
0.8 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.4 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.4 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
0.3 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 |
0.9 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.7 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 |
0.1 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.1 |
0.3 |
GO:0070352 |
positive regulation of white fat cell proliferation(GO:0070352) |
| 0.1 |
0.6 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.4 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.3 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 |
0.3 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.1 |
0.6 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
2.4 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
1.5 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.5 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.5 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.3 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.1 |
0.1 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.4 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.1 |
0.4 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
1.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.1 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.1 |
0.5 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.1 |
0.3 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.2 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
0.7 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.3 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.1 |
0.5 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.1 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.3 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
1.5 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
1.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
1.2 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.1 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.1 |
0.5 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.2 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 |
0.1 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.1 |
0.1 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.4 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
0.6 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
1.9 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
0.4 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.1 |
0.3 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.6 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
0.4 |
GO:0070293 |
renal absorption(GO:0070293) |
| 0.1 |
1.5 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.2 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.7 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.3 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
0.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.1 |
0.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.4 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.1 |
0.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.3 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
1.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
1.0 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.4 |
GO:1900920 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.1 |
0.1 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.1 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.6 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.1 |
0.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
1.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.1 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.4 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
0.7 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.4 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
1.6 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.1 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.1 |
0.9 |
GO:0006991 |
response to sterol depletion(GO:0006991) |
| 0.1 |
0.3 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
0.2 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
1.2 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.3 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.1 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.2 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.1 |
0.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
2.4 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.8 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.1 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
0.4 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.4 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.1 |
0.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.1 |
0.2 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 |
0.5 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
1.7 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.4 |
GO:0043328 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.4 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.1 |
0.4 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.4 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.2 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 |
0.3 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.7 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.1 |
0.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.1 |
GO:0071455 |
cellular response to hyperoxia(GO:0071455) |
| 0.1 |
0.3 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 |
0.2 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.1 |
0.7 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.6 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 |
0.2 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.1 |
0.2 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.4 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
0.3 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.2 |
GO:0035773 |
insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.1 |
0.6 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.1 |
GO:0034250 |
positive regulation of cellular amide metabolic process(GO:0034250) |
| 0.1 |
0.5 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.5 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.3 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.6 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.6 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
1.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
1.1 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.2 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.1 |
0.3 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.2 |
GO:1902161 |
regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.1 |
0.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.2 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.1 |
0.1 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.9 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.1 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.1 |
1.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
0.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 |
1.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.2 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.2 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.1 |
0.3 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.1 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.5 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.1 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.5 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
2.2 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.3 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 |
0.2 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
1.0 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.3 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.3 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.1 |
0.2 |
GO:0051664 |
spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.7 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.1 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.1 |
0.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.7 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
1.3 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.4 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 |
0.1 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.1 |
5.1 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.4 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 |
0.2 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.6 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.1 |
2.5 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.1 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
1.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.1 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.4 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.6 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.2 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.1 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.7 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.1 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.1 |
0.5 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 |
0.2 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 |
0.1 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 |
0.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.5 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
8.3 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.8 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.1 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.4 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 |
0.1 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.8 |
GO:0042723 |
thiamine-containing compound metabolic process(GO:0042723) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.1 |
GO:0046620 |
regulation of organ growth(GO:0046620) |
| 0.1 |
0.2 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 |
0.5 |
GO:0097531 |
mast cell migration(GO:0097531) |
| 0.1 |
0.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.1 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.1 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.1 |
GO:2000778 |
positive regulation of interleukin-6 secretion(GO:2000778) |
| 0.1 |
0.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.2 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.1 |
0.5 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.5 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.1 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.1 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.2 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.1 |
0.2 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.3 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.1 |
0.3 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.1 |
0.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.5 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
0.3 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.2 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 |
0.3 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
0.3 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.3 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.1 |
0.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.3 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.1 |
0.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.1 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.1 |
0.3 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.1 |
0.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.1 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.1 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.3 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.1 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.1 |
GO:0032200 |
telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
| 0.1 |
0.6 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
1.0 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 |
0.1 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.1 |
1.1 |
GO:0009799 |
specification of symmetry(GO:0009799) |
| 0.1 |
1.2 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.2 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.4 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.1 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.1 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 |
0.4 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.6 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.1 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.1 |
0.1 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
0.4 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.1 |
0.3 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.1 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.3 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 |
0.5 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.4 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 |
0.1 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.1 |
0.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
2.0 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.4 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
1.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.1 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.1 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.4 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 |
0.3 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.1 |
0.4 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:2000791 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.1 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.9 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.4 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) |
| 0.1 |
1.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.4 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.1 |
0.1 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.1 |
0.4 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
0.1 |
GO:0072141 |
glomerular mesangial cell differentiation(GO:0072008) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.3 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.4 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.5 |
GO:0061087 |
regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
2.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.5 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.2 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 0.1 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
0.1 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 |
0.5 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.8 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.3 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.3 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.1 |
GO:0044839 |
cell cycle G2/M phase transition(GO:0044839) |
| 0.1 |
0.2 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.1 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.1 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
0.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.1 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 |
0.5 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.1 |
0.6 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.6 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.2 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 |
0.3 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.3 |
GO:0032621 |
interleukin-18 production(GO:0032621) |
| 0.1 |
0.4 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
0.2 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.2 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
1.0 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.1 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.1 |
0.1 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.2 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 |
0.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.6 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.2 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.1 |
0.1 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.1 |
0.6 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.1 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.1 |
0.4 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.1 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.1 |
0.4 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.6 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.2 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.1 |
GO:0044829 |
modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.5 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
0.7 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.1 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.1 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.1 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.2 |
GO:0072711 |
cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.2 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.2 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
10.5 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.1 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.1 |
0.6 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.1 |
0.2 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
0.4 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.7 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
0.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.5 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.1 |
0.3 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.1 |
0.3 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.1 |
0.5 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.5 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.2 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.3 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.1 |
0.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.1 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.1 |
0.3 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.2 |
GO:0051875 |
pigment granule localization(GO:0051875) |
| 0.1 |
0.9 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.2 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.3 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.1 |
0.3 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.4 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
2.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.3 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
5.3 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
5.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.4 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.2 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.6 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
6.5 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.2 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.0 |
0.3 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
2.3 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
1.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.1 |
GO:0021816 |
lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.8 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.1 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.0 |
0.4 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.1 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.2 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.0 |
2.2 |
GO:0072413 |
signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.4 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.0 |
0.2 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 |
2.6 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.8 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.0 |
0.0 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.0 |
0.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.5 |
GO:0009157 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.0 |
0.1 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.2 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.0 |
0.0 |
GO:0060433 |
bronchus development(GO:0060433) |
| 0.0 |
0.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.0 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.0 |
0.8 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
1.2 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.0 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.0 |
GO:0014855 |
striated muscle cell proliferation(GO:0014855) |
| 0.0 |
0.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.1 |
GO:0006282 |
regulation of DNA repair(GO:0006282) |
| 0.0 |
0.5 |
GO:1903206 |
negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 |
0.2 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.0 |
0.5 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.0 |
0.2 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.3 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.1 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.0 |
0.1 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.2 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.2 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.0 |
0.0 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.0 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.7 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.0 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 |
0.1 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
1.0 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 |
0.3 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.2 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 |
0.7 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.1 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.0 |
0.4 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
0.7 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.9 |
GO:1902603 |
carnitine transmembrane transport(GO:1902603) |
| 0.0 |
0.0 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.0 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.5 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.6 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.0 |
0.2 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.0 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.3 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.0 |
0.2 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 |
0.1 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.2 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.2 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 |
0.2 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.3 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.0 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.0 |
GO:0090288 |
negative regulation of cellular response to growth factor stimulus(GO:0090288) |
| 0.0 |
0.2 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 |
0.2 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 |
0.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.2 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.1 |
GO:0040031 |
snRNA pseudouridine synthesis(GO:0031120) snRNA modification(GO:0040031) |
| 0.0 |
0.3 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.7 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
0.3 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.1 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.0 |
0.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.7 |
GO:0043482 |
pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.0 |
0.3 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
1.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.4 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.2 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.5 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.2 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.0 |
0.0 |
GO:0045950 |
regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.4 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.1 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.0 |
0.3 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 |
0.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.1 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.0 |
0.7 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 |
0.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
0.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.0 |
0.1 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.0 |
1.2 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.0 |
GO:2000617 |
positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.0 |
0.0 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.0 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.1 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 0.0 |
0.5 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.1 |
GO:0045923 |
positive regulation of fatty acid metabolic process(GO:0045923) |
| 0.0 |
0.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.3 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.0 |
0.2 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.0 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.0 |
1.1 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 |
0.2 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.0 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.0 |
0.1 |
GO:0090501 |
RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.0 |
0.2 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.0 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.0 |
0.1 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.0 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 |
0.6 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.0 |
GO:0001991 |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 |
0.3 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.5 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:1901976 |
regulation of cell cycle checkpoint(GO:1901976) |
| 0.0 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.7 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.2 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.0 |
0.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.7 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0060849 |
radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.1 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.0 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.5 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.0 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.1 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.0 |
0.1 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) |
| 0.0 |
0.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
0.2 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.3 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 |
0.5 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 |
0.1 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.0 |
0.2 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 |
0.9 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.8 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.1 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.0 |
0.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 |
0.3 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.0 |
0.5 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.4 |
GO:0070202 |
regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.0 |
0.3 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.2 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.0 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.0 |
0.1 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
1.1 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.1 |
GO:1901532 |
regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.0 |
1.1 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.4 |
GO:0014854 |
response to inactivity(GO:0014854) |
| 0.0 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.2 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.0 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.0 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 0.0 |
0.1 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 0.0 |
0.1 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.0 |
0.2 |
GO:0035303 |
regulation of dephosphorylation(GO:0035303) |
| 0.0 |
0.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 |
0.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.1 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.3 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.1 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.0 |
0.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.6 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.1 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.0 |
0.3 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.2 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.3 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.6 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.1 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:0090279 |
regulation of calcium ion import(GO:0090279) |
| 0.0 |
0.1 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.1 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 |
0.4 |
GO:0045732 |
positive regulation of protein catabolic process(GO:0045732) |
| 0.0 |
0.2 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.4 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.0 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.1 |
GO:0090114 |
COPII-coated vesicle budding(GO:0090114) |
| 0.0 |
0.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.0 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.0 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
2.3 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.0 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.0 |
0.1 |
GO:0034486 |
vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.1 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.0 |
0.1 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) |
| 0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.1 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.1 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) |
| 0.0 |
0.4 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.0 |
0.1 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.1 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.1 |
GO:0019566 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.2 |
GO:0003179 |
heart valve morphogenesis(GO:0003179) |
| 0.0 |
0.0 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.0 |
0.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.0 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.1 |
GO:2000359 |
regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.0 |
0.1 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
0.0 |
GO:1904950 |
negative regulation of establishment of protein localization(GO:1904950) |
| 0.0 |
0.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:2000329 |
peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 |
0.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.0 |
GO:0033083 |
immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) |
| 0.0 |
0.0 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.0 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
1.7 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.0 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.0 |
0.0 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.0 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.2 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.0 |
GO:0002666 |
positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
0.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.0 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.0 |
0.1 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 |
0.0 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.0 |
GO:0046502 |
uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 |
0.1 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.0 |
0.0 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.1 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.0 |
0.0 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.0 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.1 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.1 |
GO:1902883 |
negative regulation of response to oxidative stress(GO:1902883) |
| 0.0 |
0.1 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0097491 |
sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.0 |
0.1 |
GO:0009886 |
post-embryonic morphogenesis(GO:0009886) |
| 0.0 |
0.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
1.3 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.7 |
GO:0018210 |
peptidyl-threonine modification(GO:0018210) |
| 0.0 |
0.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.0 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.4 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 |
0.1 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.0 |
0.2 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.3 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.4 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.0 |
0.1 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.2 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.0 |
0.4 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.0 |
0.0 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.5 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.2 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.0 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
0.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 |
0.9 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.0 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.1 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.0 |
0.0 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) |
| 0.0 |
0.0 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.0 |
0.2 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.0 |
0.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 |
0.1 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.0 |
0.3 |
GO:0035966 |
response to topologically incorrect protein(GO:0035966) |
| 0.0 |
0.0 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.2 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 |
0.1 |
GO:0098968 |
cochlear nucleus development(GO:0021747) neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.0 |
0.1 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.2 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.1 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.0 |
0.0 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.0 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.0 |
0.1 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 |
0.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.3 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.1 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.2 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
0.0 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.2 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.1 |
GO:0050706 |
interleukin-1 beta secretion(GO:0050702) regulation of interleukin-1 beta secretion(GO:0050706) |
| 0.0 |
0.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.1 |
GO:0038123 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.0 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.0 |
0.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.1 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.0 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.7 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.0 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.9 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.2 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.0 |
0.1 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.0 |
0.1 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.0 |
0.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.1 |
GO:0038188 |
cholecystokinin signaling pathway(GO:0038188) |
| 0.0 |
0.0 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.1 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.4 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.0 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.0 |
0.2 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0032680 |
regulation of tumor necrosis factor production(GO:0032680) |
| 0.0 |
0.1 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.3 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.3 |
GO:0010810 |
regulation of cell-substrate adhesion(GO:0010810) |
| 0.0 |
0.1 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.1 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.0 |
0.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.1 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.0 |
0.0 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.2 |
GO:0044728 |
DNA methylation or demethylation(GO:0044728) |
| 0.0 |
0.0 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.0 |
0.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.0 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.0 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.0 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.0 |
0.1 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.0 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.1 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.0 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.0 |
0.3 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.0 |
0.3 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.4 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.1 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.8 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.0 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.0 |
0.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.0 |
0.2 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.0 |
0.0 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.4 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 |
0.0 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.0 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.0 |
0.0 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.0 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.0 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0061614 |
pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
| 0.0 |
0.0 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.0 |
0.1 |
GO:0045785 |
positive regulation of cell adhesion(GO:0045785) |
| 0.0 |
0.0 |
GO:0010634 |
positive regulation of epithelial cell migration(GO:0010634) |
| 0.0 |
0.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.0 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.0 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.0 |
0.0 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.0 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.0 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.0 |
0.0 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.0 |
0.7 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.0 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.0 |
0.0 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.0 |
GO:0035194 |
posttranscriptional gene silencing by RNA(GO:0035194) |
| 0.0 |
0.2 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.0 |
0.7 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.1 |
GO:2000816 |
negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 |
0.0 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 0.0 |
0.1 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0060841 |
venous blood vessel development(GO:0060841) |
| 0.0 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
1.6 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.0 |
0.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.6 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.0 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.7 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.0 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
0.0 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 |
0.1 |
GO:0031179 |
peptide amidation(GO:0001519) peptide modification(GO:0031179) |
| 0.0 |
0.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.0 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.0 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.0 |
0.0 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
1.7 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.0 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.0 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 |
0.0 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.4 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.6 |
GO:0002223 |
stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 |
0.1 |
GO:0021795 |
cerebral cortex cell migration(GO:0021795) |
| 0.0 |
0.0 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.0 |
0.1 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.2 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.2 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.1 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.0 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.0 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.0 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
0.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
